I like the Ann and have been watching this company for a while now from a distance.
The doesn’t seem to have put a wrong foot forward and that is kudos to mgmt and BOD.
What do you think of the pace of progress in the trials? How is mgmt doing and are you in this for the long term?
Cheers.
Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-3
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.001(1.59%) |
Mkt cap ! $11.12M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.5¢ | 6.2¢ | $3.61K | 56.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 80 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
-0.001 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.3¢ | 6.3¢ | 43043 | ||
| Last updated 15.09pm 24/05/2024 ? | |||||
| NYR (ASX) Chart |